John Wilkin
Stock Analyst at Craig-Hallum
(1.48)
# 3,361
Out of 4,944 analysts
5
Total ratings
60%
Success rate
-0.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by John Wilkin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XGN Exagen | Initiates: Buy | $12 | $9.58 | +25.26% | 1 | Jul 23, 2025 | |
| ADPT Adaptive Biotechnologies | Initiates: Buy | $15 | $12.96 | +15.74% | 1 | Jun 18, 2025 | |
| VCYT Veracyte | Initiates: Buy | $45 | $29.28 | +53.69% | 1 | Mar 20, 2025 | |
| PSNL Personalis | Initiates: Buy | $8 | $4.71 | +69.85% | 1 | Mar 17, 2025 | |
| MYGN Myriad Genetics | Initiates: Buy | $29 | $6.12 | +373.86% | 1 | Feb 12, 2025 |
Exagen
Jul 23, 2025
Initiates: Buy
Price Target: $12
Current: $9.58
Upside: +25.26%
Adaptive Biotechnologies
Jun 18, 2025
Initiates: Buy
Price Target: $15
Current: $12.96
Upside: +15.74%
Veracyte
Mar 20, 2025
Initiates: Buy
Price Target: $45
Current: $29.28
Upside: +53.69%
Personalis
Mar 17, 2025
Initiates: Buy
Price Target: $8
Current: $4.71
Upside: +69.85%
Myriad Genetics
Feb 12, 2025
Initiates: Buy
Price Target: $29
Current: $6.12
Upside: +373.86%